Announcements

Xenon Pharmaceuticals Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, registering an additional 300,000 common shares under its Amended and Restated 2025 Inducement Equity Incentive Plan.

Tecnoglass Holdings Inc. filed a Form 8-K/A (Amendment No. 1) on November 9, 2026, correcting its previously reported third-quarter and nine-month 2026 financial results to reflect a valuation allowance on a deferred tax asset related to treasury stock accounting.

Tecnoglass Holdings Inc. (NYSE:TGLS) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting total operating revenues of $310.6 million for the third quarter and net income of $16.7 million.

Xenon Pharmaceuticals Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing balance sheet data showing total assets of $1,199,875 thousand and an accumulated deficit of $1,568,853 thousand.

Office Properties Income Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, covering results both before and after the company's emergence from Chapter 11 bankruptcy proceedings.

JBS N.V. filed a Form 8-K with the SEC on November 9, 2026, disclosing that it issued an earnings release covering results for the quarter ended September 30, 2026.

JBS N.V. filed a Form 8-K on November 9, 2026, disclosing that its wholly owned Brazilian subsidiary JBS S.A. entered into two share purchase agreements to acquire Flora Produtos de Higiene e Limpeza S.A. and Canal Rural Produções Ltda. from related party J&F S.A.